Schweizerischer Nationalfonds / Fonds national suisse
Animal experiments and 3R: Interview with animal ethicist Herwig Grimm
mehr
Storys zum Thema Medizin, Gesundheit
-
Sprache:
Englisch
- Medien:
- Zeitraum:
- Zeitraum:Gesamt
Parity Technologies and MediLedger Network Announce Partnership to Deliver Blockchain-Powered Solutions to the Life Sciences Industry
San Francisco (ots/PRNewswire) - Companies to apply technology originally developed to address drug safety, to pricing accuracy, chargeback automation, and other supply chain solutions Chronicled, the technology company behind MediLedger Network, has entered into a partnership with Parity Technologies, the developer ...
mehrZentiva awarded Top Employer accolade
Prague (ots/PRNewswire) - The Top Employee Institute has certified Zentiva as a Top Employer. This prestigious award was received for Zentiva's exceptional standards across 6 Human Resources-domains in its home countries the Czech Republic and Romania. The assessment was covering 20 topics including People Strategy, Work Environment, Talent Acquisition, Learning, Well-being, Diversity & Inclusion, and many more. "I am ...
mehrALDER HEY AND NEEDLESMART PARTNERSHIP AIMS TO REDUCE 100,000 NEEDLESTICK INJURIES TO NHS HEALTHCARE WORKERS
mehrServier Group Reports Financial Year 2020/2021 Annual Results, R&D Strategy and Pipeline
Paris (ots/PRNewswire) - - Consolidated revenue of €4.725 billion, up +4.3% at constant rates (+0.8% at current rates) - Revenue for brand-name medicines of €3.306 billion +4.8% at constant rates (+0.6% at current rates) and €1.419 billion for the generics +2.9% at constant rates (+1.1% at current rates) - An accelerated oncology strategy with the acquisition of ...
mehrOri Biotech raises over $100 million in Series B funding to launch innovative cell and gene therapy manufacturing platform
London (ots/PRNewswire) - Ori Biotech Ltd. (Ori), a leader in cell and gene therapy (CGT) manufacturing technology, today announces it has secured over $100 million in an oversubscribed Series B funding round. The investment round was led by Novalis LifeSciences with Puhua Capital and Chimera Abu Dhabi coming in as ...
mehr
Schweizerischer Nationalfonds / Fonds national suisse
Animal experiments and 3R: Immune cells live in a complex world
Bern (ots) - Some research relies almost entirely on animal models. An example is the SNSF-funded project on virus surveillance in the mouse brain. "The immune system has a place where it is born, a place where it is educated and a place where it goes to work." Natalia Pikor, research group leader at St. Gallen cantonal hospital, is studying one of the most complicated systems in the bodies of vertebrate animals and ...
mehrPoda Lifestyle and Wellness Ltd.
PODA Granted US Patent for Closed Bottom Vaporizer Pod
Vancouver, Bc (ots/PRNewswire) - PODA HOLDINGS, INC. ("Poda" or the "Company") (CSE: PODA) (FSE: 99L) (OTCQB: PODAF) is pleased to announce that it has been granted a US Patent by the US Patent and Trademark Office concerning US Application 16/340,058 for Poda's Closed Bottom Vaporizer Pod. US Patent 11,206,869 B2 was granted on December 28th, 2021. Mr. Ryan Selby, CEO of the Company, commented, "Receiving this Notice of ...
mehrDALI Medical's SAN®Light Passive Safety Needle coupled with a novel Drug Product, Enabling User-friendly Administration
Tel Aviv, Israel (ots/PRNewswire) - DALI Medical Devices, an innovative developer and distributor of drug delivery devices, today announced the first commercial implementation of its SAN-Light passive safety needle. SAN-Light was chosen to be used with ADVANZ PHARMA's MYTOLAC®/MYRELEZ® - the first generic ...
mehrPoda Lifestyle and Wellness Ltd.
PODA Signs Letter of Intent to Partner with 170-year-old European Tobacco Company - Landewyck Tobacco
Vancouver, Bc (ots/PRNewswire) - PODA HOLDINGS, INC. ("Poda" or the "Company") (CSE: PODA) (FSE: 99L) (OTCQB: PODAF) is pleased to announce that it has signed a letter of intent ("LOI") with Landewyck Tobacco S.A. ("Landewyck") (collectively the "Parties"). In the year 1847, Josephine van Landewyck and Jean-Pierre ...
mehrSchweizerischer Nationalfonds / Fonds national suisse
Animal experiments and 3R: mucous membrane as a model
Bern (ots) - In an SNSF-funded project, researchers are studying how bacteria infect the lungs. They are developing an alternative to animal testing that complements existing methods. When bacteria enter our lungs or live in our guts, they physically interact with our own cells that line the openings of our body like a protective layer. Some bacteria help us digest, others make us sick. Alexandre Persat from EPF Lausanne ...
mehrPoda Receives Final Approval from OTC Markets to List on the QTCQB
Vancouver, Bc (ots/PRNewswire) - PODA HOLDINGS, INC. ("Poda" or the "Company") (CSE: PODA) (FSE: 99L) (OTC: PODAF) is pleased to announce the Company has received official notification from OTC Markets to up-list from Pink Sheet to the OTCQB tier effective as of January 6, 2022. The OTCQB is a US trading platform that is operated by the OTC Markets Group in New York. The Company will trade on the OTCQB exchange under ...
mehr
DEBIOPHARM IINVESTS IN VERISIM LIFE’S $15M SERIES A ROUND TO ADVANCE AI-ENABLED DRUG RESEARCH
Lausanne, Switzerland - San Francisco (ots) - Funding to support BIOiSIMTM computational platform to reduce the need for animal testing by selecting compounds showing promise to cure a disease prior to research in humans Debiopharm (www.debiopharm.com), a Swiss biopharmaceutical company, announced today their co-investment in California-based start-up VeriSIM Life’s ...
mehrVeriSIM Life Secures $15 Million Series A Funding
San Francisco, CA (ots) - Financing led by Morpheus Ventures supports further revenue growth for the company’s next-generation AI platform, redefining the preclinical translational drug development landscape by accurately predicting and accelerating clinical outcomes VeriSIM Life (VeriSIM) www.verisimlife.com, the leading artificial intelligence (AI)-enabled, unique R&D decisions de-risker for breakthrough drug ...
mehrSchweizerischer Nationalfonds / Fonds national suisse
Animal experiments and 3R: Wound healing in mice and cell cultures
Bern (ots) - Research projects involving animal experiments employ a variety of methods. An SNSF-funded project on skin diseases, ulcers and cancer exemplifies this. Sabine Werner, professor of cell biology at ETH Zurich, studies how wounds heal. Knowledge of cell and tissue processes helps to better understand, diagnose and treat certain skin diseases. Here the focus is not primarily cuts and abrasions but rather wounds ...
mehrAlamar Biosciences partners with Abcam to drive understanding of the human proteome
Fremont, Calif. and Cambridge, England (ots/PRNewswire) - Alamar Biosciences (Alamar), a platform company focused on transforming the field of proteomics to enable the early detection of cancer and other diseases, and Abcam (AIM: ABC) (NASDAQ: ABCM), a global innovator in life sciences research tools, today announced a strategic partnership to further understanding of ...
mehrEssence Group Announces Success in Meeting Supply Demand Throughout 2021, Despite Major Chip Shortages Caused by Ongoing COVID-19 Disruption
Herzliya, Israel (ots/PRNewswire) - Efficient Supply Chain Management, Including Advanced Forecasting and Component Sourcing, Resulted in Essence's 99.5% On-Time Delivery of Customer Orders Essence Group, a leading technology group developing IoT-based security, safety and healthcare solutions and cloud services for ...
mehrSchweizerischer Nationalfonds / Fonds national suisse
Gut bacteria linked to infant sleep patterns
Bern (ots) - A study funded by the Swiss National Science Foundation shows that the link between sleep behaviour and intestinal flora is already present in infancy. The gut flora of infants is connected to their sleep patterns. This effect is evident from the age of three months, as sleep researchers Salome Kurth of the University of Fribourg and Sarah Schoch of the University of Zurich have now shown. For example, ...
mehr
Cardiovascular Startup, Filterlex Medical, Selected to Receive €7M from the European Innovation Council
Caesarea, Israel (ots/PRNewswire) - Filterlex Medical, a cardiovascular medical device startup, announced today that it has been selected to receive €7 Million equity investment from the European Innovation Council Accelerator (EIC). The EIC equity investment will be a part of Filterlex's next round of financing. ...
mehrNovaliq Announces POSITIVE Topline Results for SECOND PHASE 3 TRIAL (ESSENCE-2) of CyclASol® in Dry Eye Disease
Heidelberg, Germany and Cambridge, Mass (ots/PRNewswire) - Novaliq, a biopharmaceutical company focusing on first- and best-in-class ocular therapeutics based on the unique EyeSol® water-free technology, today announced key results of the second pivotal Phase 3 trial (ESSENCE-2) evaluating the investigational drug ...
mehrOrganOx receives FDA approval for its liver normothermic machine perfusion system
Oxford, England (ots/PRNewswire) - OrganOx, a world leader in normothermic machine perfusion (NMP), today announced that the U.S. Food and Drug Administration (FDA) has granted premarket approval (PMA) of its metra system. The OrganOx metra is a fully automated NMP device for the preservation and transport of donor livers destined for transplantation. The marketing ...
mehrNorgine B.V. announces Senior Management changes: Christopher Bath appointed Chief Executive Officer - Peter Stein to assume role of Executive Chairman
Amsterdam (ots/PRNewswire) - Norgine B.V. (Norgine), a leading European specialist pharmaceutical company, today announces that Christopher Bath has been appointed Chief Executive Officer (CEO) effective 1st January 2022. Chris will be responsible for a business with a portfolio of market leading medicinal products ...
mehrDEBIOPHARM FURTHER EXPLORES THE POTENTIAL OF ITS POTENT, HIGHLY SELECTIVE WEE1 INHIBITOR DEBIO 0123 IN PHASE 1 CANCER STUDY
Lausanne, Switzerland (ots) - Dose escalation, monotherapy trial launched to access the safety and preliminary anti-tumor activity of Debio 0123 in the treatment of advanced solid tumors Debiopharm (www.debiopharm.com), a Swiss biopharmaceutical company, announced today the first patient treated in the newly ...
mehrPHASE 3 TRIAL OF SHR8058 EYE DROPS (PERFLUOROHEXYLOCTANE) CONDUCTED BY JIANGSU HENGRUI PHARMACEUTICALS IN THE PEOPLE'S REPUBLIC OF CHINA SHOWS STATISTICALLY SIGNIFICANT TOPLINE RESULTS
Heidelberg, Germany, and Cambridge, Mass. (ots/PRNewswire) - Novaliq, a biopharmaceutical company focusing on first- and best-in-class ocular therapeutics based on the unique EyeSol® water-free technology, today provided a development update on the phase 3 trial of SHR8058 eye drops (perfluorohexyloctane) for the ...
mehr
BenevolentAI achieves second major collaboration milestone with novel idiopathic pulmonary fibrosis target selected for AstraZeneca's portfolio
London (ots/PRNewswire) - - Novel target for idiopathic pulmonary fibrosis was discovered using BenevolentAI's AI-drug discovery platform and experimentally validated by AstraZeneca - Announcement represents the second collaboration milestone following the addition of a novel chronic kidney disease target to ...
mehrSchweizerischer Nationalfonds / Fonds national suisse
Wastewater provides new insight into Covid-19 dynamics
Bern (ots) - An interdisciplinary team funded by the Swiss National Science Foundation shows that the R number of coronavirus can be estimated quickly and cost-effectively from wastewater. Since the start of the coronavirus (Sars-Cov-2) pandemic, many public health measures have been decided based on its dynamic of spread, more precisely, on the reproductive number of the virus, known as the R number. This value indicates ...
mehrMenarini Silicon Biosystems Announces Study Results Presented at American Society of Hematology (ASH) Annual Meeting
Bologna, Italy and Huntingdon Valley, Pa. (ots/PRNewswire) - Menarini Silicon Biosystems Announces Study Results Presented at American Society of Hematology (ASH) Annual Meeting Highlighting CELLSEARCH® CMMC assay, a Non-Invasive Liquid Biopsy for the Quantification and Molecular Characterization of Circulating ...
mehrMars Petcare Europe to Launch Petfood Packaging with Food Safe Recycled Content
Brussels (ots/PRNewswire) - - Mars Petcare is getting ready to deploy petfood pouches of SHEBA® containing recycled plastic from advanced recycling techniques - Deployment is set to begin in Europe in 2022 - With this move, Mars Petcare becomes the first in pet food industry to deploy food safe recycled plastic as part of its wet petfood packaging - The initiative is ...
mehrUnited Nations recommends bioplastics as a sustainable alternative to conventional plastics
Berlin (ots) - The Food and Agriculture Organisation of the United Nations (FAO) recently published a report assessing the sustainability of agricultural plastic products.[1] "The report recommends replacing non-biodegradable conventional polymers with biodegradable bio-based polymers. We welcome this recognition of ...
mehrNew HARMONY Acute Myeloid Leukemia (AML) and Chronic Lymphocytic Leukemia (CLL) Research Results from HARMONY to facilitate tailored treatment choices in subtypes of blood cancer
The Hague, The Netherlands (ots/PRNewswire) - - Big Data analyses have produced novel insights that may improve the prognostication of patients with AML and CLL - These results may be used to identify high-risk patients and to make better-informed treatment choices in the future - The new data is presented at the ...
mehr
Vorherige891011121314151617Nächste